Neuburgh Advisers’s Pfizer PFE Stock Holding History

Neuburgh Advisers’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$22.9M	Sell	671,065 -132,127	-16%	-$4.8M	0.71%	33
2019 Q2	$33M	Sell	803,192 -73,930	-8%	-$2.94M	1.06%	20
2019 Q1	$35.3M	Buy	877,122 +66,619	+8%	+$2.67M	1.2%	19
2018 Q4	$33.6M	Buy	810,503 +81,993	+11%	+$3.4M	1.32%	15
2018 Q3	$30.5M	Buy	728,510 +59,309	+9%	+$2.28M	0.98%	23
2018 Q2	$23M	Buy	669,201 +28,059	+4%	+$959K	0.77%	33
2018 Q1	$21.6M	Buy	641,142 +73,141	+13%	+$2.51M	0.76%	36
2017 Q4	$19.5M	Buy	568,001 +107,437	+23%	+$3.66M	0.7%	38
2017 Q3	$15.6M	Buy	460,564 +75,900	+20%	+$2.44M	0.58%	44
2017 Q2	$12.3M	Buy	384,664 +83,857	+28%	+$2.64M	0.46%	57
2017 Q1	$9.76M	Buy	300,807 +88,765	+42%	+$2.8M	0.39%	57
2016 Q4	$6.53M	Buy	+212,042	New	+$6.47M	0.29%	73

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Neuburgh Advisers's PFE Position: Q3 2019 in Review

Neuburgh Advisers reduced its Pfizer (PFE) stake by 16% in Q3 2019, selling an estimated $4.8M and leaving 671,065 shares worth $22.9M. The position accounts for 0.71% of the portfolio, ranked #33.

Neuburgh Advisers first reported a position in PFE in Q4 2016 and has held it in 12 quarters since. The position peaked at $35.3M in Q1 2019. 2,322 funds tracked by Wall St. Rank hold PFE as of Q3 2019.

Neuburgh Advisers held 671,065 shares of Pfizer worth $22.9M as of Q3 2019.
Neuburgh Advisers sold 132,127 Pfizer shares in Q3 2019, an estimated $4.8M.
Pfizer made up 0.71% of Neuburgh Advisers's portfolio in Q3 2019, its #33 holding.
Neuburgh Advisers first reported a position in Pfizer in Q4 2016 and has held it in 12 quarters since.
Neuburgh Advisers's Pfizer position peaked at $35.3M in Q1 2019.
2,322 funds tracked by Wall St. Rank held Pfizer as of Q3 2019.

Based on Neuburgh Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.